Terms: = Liver cancer AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968
6 results:
1. Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
Tan W; Peng S; Li Z; Zhang R; Xiao Y; Chen X; Zhu J; Li B; Lv X
Comput Math Methods Med; 2022; 2022():2021613. PubMed ID: 35069777
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence of Forceps Polypectomy of Nondiminutive Polyps Is Substantial But Modifiable.
Fudman DI; Singal AG; Cooper MG; Lee M; Murphy CC
Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1508-1515. PubMed ID: 34839039
[TBL] [Abstract] [Full Text] [Related]
3. Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila.
Li X; Liu M; Ji JY
Adv Exp Med Biol; 2019; 1167():129-155. PubMed ID: 31520353
[TBL] [Abstract] [Full Text] [Related]
4. SET domain containing 1B gene is mutated in primary hepatic neuroendocrine tumors.
Yang P; Huang X; Lai C; Li L; Li T; Huang P; Ouyang S; Yan J; Cheng S; Lei G; Wang Z; Yu L; Hong Z; Li R; Dong H; Wang C; Yu Y; Wang X; Li X; Wang L; Lv F; Yin Y; Yang H; Song J; Gao Q; Wang X; Zhang S
Int J Cancer; 2019 Dec; 145(11):2986-2995. PubMed ID: 30977120
[TBL] [Abstract] [Full Text] [Related]
5. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
6. GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition.
Enane FO; Shuen WH; Gu X; Quteba E; Przychodzen B; Makishima H; Bodo J; Ng J; Chee CL; Ba R; Seng Koh L; Lim J; Cheong R; Teo M; Hu Z; Ng KP; Maciejewski J; Radivoyevitch T; Chung A; Ooi LL; Tan YM; Cheow PC; Chow P; Chan CY; Lim KH; Yerian L; Hsi E; Toh HC; Saunthararajah Y
J Clin Invest; 2017 Sep; 127(9):3527-3542. PubMed ID: 28758902
[TBL] [Abstract] [Full Text] [Related]
